Word

NEXT LEVEL IMMUNO-ONCOLOGY

Status

Pending

Status Code

645

Status Date

Tuesday, February 6, 2024

Serial Number

97207825

Mark Type

5000

Filing Date

Friday, January 7, 2022

Trademark Owner History

Beyond Cancer, Ltd

Classifications

5 Pharmaceutical preparations and articles, namely, medical gas being nitric oxide for medical purpose to be used at home or in a hospital; gases for medical purposes, namely, nitric oxide for medical purposes and ultra-high nitric oxide for the treatment of tumors and cancer; chemical preparations for medical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; chemical preparations for pharmaceutical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Pharmaceutical preparations for treating tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Medical preparations for the treatment of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium

10 Medical apparatus and instruments for medical and therapeutic purposes, namely, an immunotherapy for patients with solid tumors and other cancer to be treated in a hospital operating room or an outpatient setting; a contained system composed of a drug product packaged in a cylinder with a valve comprised of ultra-high concentrations of nitric oxide balanced with nitrogen gas for the treatment of solid tumors and other cancer, a delivery apparatus comprised of instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients, and co-packaged medical tubing and applicators comprised of materials capable of delivering nitric oxide to tumor tissue

42 Scientific research for medical purposes in the area of tumors, cancer, and respiratory diseases; medical research services, namely, conducting clinical trials for others; scientific research, namely, research on the use of nitric oxide and ultra-high nitric oxide for medical purposes; Scientific research, namely, research on preparations and treatments for tumors, cancer, and respiratory diseases

The mark consists of the wording "NEXT LEVEL IMMUNO-ONCOLOGY" in stylized form.
Color is not claimed as a feature of the mark.
"IMMUNO-ONCOLOGY"

Trademark Events

Feb 6, 2024

Notification Of Final Refusal Emailed

Feb 6, 2024

Final Refusal E-Mailed

Feb 6, 2024

Final Refusal Written

Jan 2, 2024

Suspension Checked - To Attorney For Action

Dec 6, 2023

Teas Withdrawal Of Attorney Received-Firm Retains

Dec 6, 2023

Teas Change Of Correspondence Received

Dec 6, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Dec 6, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Dec 6, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Dec 6, 2023

Teas Change Of Owner Address Received

Jul 7, 2023

Teas Change Of Correspondence Received

Jul 7, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Jul 7, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jul 7, 2023

Teas Change Of Correspondence Received

Jul 7, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Jul 7, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Apr 26, 2023

Notification Of Letter Of Suspension E-Mailed

Apr 26, 2023

Letter Of Suspension E-Mailed

Apr 26, 2023

Suspension Letter Written

Apr 18, 2023

Teas/Email Correspondence Entered

Apr 17, 2023

Correspondence Received In Law Office

Apr 17, 2023

Teas Response To Office Action Received

Oct 17, 2022

Notification Of Non-Final Action E-Mailed

Oct 17, 2022

Non-Final Action E-Mailed

Oct 17, 2022

Non-Final Action Written

Oct 14, 2022

Assigned To Examiner

Jan 13, 2022

New Application Office Supplied Data Entered

Jan 11, 2022

New Application Entered